BWA vs SUPN · P/E 41, rev $7.18B vs rev $426.8M
BorgWarner Inc (BWA) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
BorgWarner Inc (BWA) is a auto parts company listed on NYSE.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BWA revenue for 2026-06-30 was $7.18B. Net income was $519.0M. BWA currently screens at market cap $14.47B and trailing P/E 41.0.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
BWA currently screens at market cap $14.47B and trailing P/E 41.0. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the BWA and SUPN stock pages for the full models.
Not investment advice.